Exotropin, LLC v. DP Derm, LLC

CourtDistrict Court, S.D. Florida
DecidedAugust 8, 2025
Docket1:25-cv-20713
StatusUnknown

This text of Exotropin, LLC v. DP Derm, LLC (Exotropin, LLC v. DP Derm, LLC) is published on Counsel Stack Legal Research, covering District Court, S.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Exotropin, LLC v. DP Derm, LLC, (S.D. Fla. 2025).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF FLORIDA

Case No. 25-cv-20713-BLOOM/Elfenbein

EXOTROPIN, LLC, Plaintiff, v. DP DERM, LLC and BIOSOFT (AUSTRALIA) PTY LTD,

Defendants. /

ORDER ON MOTION TO DISMISS

THIS CAUSE is before the Court upon Defendant DP Derm, LLC (“DP Derm”) and Biosoft (Australia) Pty Ltd (“Biosoft”) (collectively “Defendants”) Motion to Dismiss Complaint, or in the Alternative, to Transfer this Case to the United States District Court for the District of Utah (“Motion”), ECF No. [27]. Exotropin (“Plaintiff”) filed a Response in Opposition (“Response”), ECF No. [36], to which Defendants filed a Reply, ECF No. [41]. The Court has carefully reviewed the Motion, the record in this case, the applicable law, and is otherwise fully advised. For the reasons discussed below, the Motion is denied. I. BACKGROUND Plaintiff, a research and development firm that formulates skin care solutions, is duly organized and existing under the laws of Delaware and has its principal address in Delaware. ECF No. [15] at ¶¶ 3, 22. Plaintiff’s cosmetic products can be found within over fifty retail locations throughout the United States — fifteen of which are in South Florida — as well as through online retailers. Id. at ¶ 25. Biosoft is an Australian proprietary limited company with a business address in Australia. Id. at ¶ 5. The U.S. distributor for Biosoft, DP Derm, is a Florida limited liability company duly organized and existing under the laws of Florida. Id. at ¶¶ 4, 8. DP Derm also conducts business in Florida and has a principal address in Miami. Id. Biosoft has authorized DP Derm to sell its

products, including those that bear the “EXO SKIN” mark, in the United States and the Southern District of Florida. Id. at ¶ 8. The goods bearing the mark are advertised and offered for sale on two websites, which can be accessed from anywhere in the U.S. Id. at ¶¶ 36-37. On April 11, 2024, Biosoft, despite knowing full well of Plaintiff and its prior use of its ‘EXO SKIN SIMPLE’ mark and ‘EXO SKIN SIMPLE’ Registration, filed multiple U.S. trademark applications for its own “EXO SKIN” mark for competing cosmetic goods. Id. at ¶ 33. Several months later, on September 11, 2024, Biosoft filed three Notices of Opposition in the United States Patent and Trademark Office Trademark Trial and Appeal Board (“TTAB”) against Plaintiff’s applications for the “EXO SKIN” mark, “EXO BODY” mark, and “EXO MEN” mark. Id. at ¶ 40. In the TTAB proceedings, Biosoft alleged that Plaintiff’s three marks are likely

to be confused with the “EXO SKIN” mark that Biosoft uses for its products. Id. at 41. Plaintiff argued that Biosoft has made “the same allegations of likelihood of confusion between [Plaintiff’s] “EXO SKIN SIMPLE” Mark and Biosoft’s “EXO SKIN” mark being made by [Plaintiff] in the instant action.” Id. at 42. On September 24, 2024, Plaintiff sent a cease-and-desist letter to Biosoft’s U.S. counsel, demanding that Biosoft cease and desist using the infringing mark, abandon its trademark applications, and withdraw the TTAB proceedings. Id. at ¶ 43. On October 10, 2024, Biosoft’s counsel responded, requesting “‘another two weeks to prepare a substantive response to [the] letter’ and making the representation that he will be ‘working with [his] client on a substantive response . . . including a potential resolution of the present dispute.” Id. at ¶ 44 (emphasis omitted). That same day, Biosoft filed an action for declaratory judgment in the District of Utah. Id. at ¶ 45. Without divulging that an anticipatory action had been filed in the District of Utah, and under the pretense that the parties were engaged in settlement discussions, Biosoft consented to a

thirty-day extension of time of all deadlines in the TTAB Proceedings, including Plaintiff’s deadline to file its responses to the Notices of Opposition. Id. at ¶ 46. Moreover, Plaintiff alleges that Biosoft, claiming that a settlement proposal would still be forthcoming, consented to two additional thirty-day extensions of time of all deadlines in the TTAB proceedings, without notifying Plaintiff of the action that had been filed in the District of Utah. Id. at ¶ 47. Biosoft never served Plaintiff with initial process in that action, and when the deadline to serve Plaintiff approached, Biosoft filed a second action in the District of Utah seeking the same relief. Id. at ¶ 48. Plaintiff argues that it was only after filing this action for infringement in the Southern District of Florida and serving DP Derm that Biosoft proceeded to serve Plaintiff with initial

process related to the Utah action. Id. at ¶ 49. To date, despite repeated representations from Biosoft’s counsel that Biosoft would be making a settlement proposal, no proposal has been received. Id. at ¶ 50. Defendants seek dismissal of the Amended Complaint, asserting that the Court lacks subject matter jurisdiction, or, in the alternative, Defendants seek to transfer this case to the United States District Court for the District of Utah under the first-to-file rule, or 28 U.S.C. § 1404(a). ECF No. [27]. Defendants argue that venue in Utah is proper because Plaintiff sent a cease-and- desist letter to the Utah counsel of all three Defendants, Plaintiff has a website accessible to Utah residents, and one of Plaintiff’s thirty-five retail locations is in Park City, Utah. ECF No. [27-1] Ex. A at ¶¶ 6-8. Plaintiff responds that Defendants’ Motion should be denied because Defendants are attempting to improperly leverage the first-to-file rule and the District of Utah is not a proper

venue. ECF No. [36] at 1. First, Plaintiff argues that Defendants’ filing of two declaratory actions in the District of Utah was anticipatory and urges the Court to exercise its discretion to decline application of the first-to-file rule. Id. at 2. Plaintiff further asserts that transfer to Utah is improper because the District of Utah lacks personal jurisdiction over Plaintiff, and the 28 U.S.C. § 1404 venue-transfer factors do not favor Defendants. Id. at 6-11. Defendants reply that they filed their declaratory judgment actions in Utah in good faith after Plaintiff threatened litigation. ECF No. [41] at 3. They further contend that the first-to-file rule strongly supports dismissal or transfer of this action. Id. Finally, Defendants assert that Plaintiff is subject to personal jurisdiction in Utah because it purposefully directed its conduct toward Utah by sending a cease-and-desist letter, operating a website that sells products to Utah

residents, and maintaining a retail location in Utah. Id. at 5. II. LEGAL STANDARD A. First-to-File Rule

“The first-filed rule provides that when parties have instituted competing or parallel litigation in separate courts, the court initially seized of the controversy should hear the case.” Alers v. Robinhood Fin. LLC, Case No. 21-CV-61848, 2022 WL 2431522, at *2 (S.D. Fla. July 1, 2022) (quoting Collegiate Licensing Co. v. Am. Cas. Co. of Reading, Pa., 713 F.3d 71, 78 (11th Cir. 2013)). In applying the rule, courts consider three factors: “(1) the chronology of the two actions, (2) the similarity of the parties, and (3) the similarity of the issues.” Women’s Choice Pharms., LLC v. Rook Pharms., Inc., Case No. 16-cv-62074, 2016 WL 6600438, at *2 (S.D. Fla. Nov. 8, 2016). Neither the parties nor the issues need to be identical; they just need to overlap. Kelly v. Gerber Prods. Co., CASE NO. 21-60602-CIV, 2021 WL 2410158, at *1 (S.D. Fla. June 11, 2021).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Robinson v. Giarmarco & Bill, P.C.
74 F.3d 253 (Eleventh Circuit, 1996)
William S. Manuel v. Convergys Corporation
430 F.3d 1132 (Eleventh Circuit, 2005)
International Shoe Co. v. Washington
326 U.S. 310 (Supreme Court, 1945)
Burger King Corp. v. Rudzewicz
471 U.S. 462 (Supreme Court, 1985)
Employers Mutual Casualty Co. v. Bartile Roofs, Inc.
618 F.3d 1153 (Tenth Circuit, 2010)
Shrader v. Biddinger
633 F.3d 1235 (Tenth Circuit, 2011)
Radio Systems Corp. v. Accession, Inc.
638 F.3d 785 (Federal Circuit, 2011)
Goodyear Dunlop Tires Operations, S. A. v. Brown
131 S. Ct. 2846 (Supreme Court, 2011)
In Re Ricoh Corporation
870 F.2d 570 (Eleventh Circuit, 1989)
Burger King Corp. v. Thomas
755 F. Supp. 1026 (S.D. Florida, 1991)
MOTOROLA MOBILITY, INC. v. Microsoft Corp.
804 F. Supp. 2d 1271 (S.D. Florida, 2011)
Windmere Corp. v. Remington Products, Inc.
617 F. Supp. 8 (S.D. Florida, 1985)
Mason v. Smithkline Beecham Clinical Laboratories
146 F. Supp. 2d 1355 (S.D. Florida, 2001)
Stiefel Laboratories, Inc. v. Galderma Laboratories, Inc.
588 F. Supp. 2d 1336 (S.D. Florida, 2008)
Jonathan E. Perlman, Esq. v. Dorothy Delisfort-Theodule
451 F. App'x 846 (Eleventh Circuit, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Exotropin, LLC v. DP Derm, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/exotropin-llc-v-dp-derm-llc-flsd-2025.